Treatment of Advanced Squamous Cell Lung Cancer
Lung cancer is the deadliest cancer in the worldwide. Non-small cell lung cancer (NSCLC) accounts for 85% of lung tumor diagnoses. Squamous cell lung cancer (SQCLC) is a common pathological type, almost 20%-30% of NSCLC. Surgery, chemotherapy, and molecular targeted therapies are the mainstay of tre...
Main Authors: | Yixiang ZHU, Puyuan XING, Junling LI |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2016-10-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2016.10.10 |
Similar Items
-
Progress in Treatment of Advanced Squamous Cell Lung Cancer
by: Ming GAO, et al.
Published: (2020-10-01) -
Effects of Erlotinib on 34 Patients with Advanced Squamous Cell Lung Cancer
by: Fang CHENG, et al.
Published: (2016-10-01) -
The Role of Adjuvant Chemotherapy in Operable Non-small Cell Lung Cancer
by: Xiangtao YAN, et al.
Published: (2011-03-01) -
Recent Advances and Future Strategies for Small Cell Lung Cancer
by: Weipeng SHAO, et al.
Published: (2017-06-01) -
Advances of Molecular Targeted Therapy in Squamous Cell Lung Cancer
by: Li MA, et al.
Published: (2013-12-01)